Key facts
- This page summarizes Allison Dorval's Form 4 filing for Aerovate Therapeutics, Inc. (JBIO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 07 Jun 2024, 18:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The shares subject to this option will vest and become exercisable in full on the earlier of (i) June 5, 2025 or (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date.